Table 1.

Demographic and clinical data at the time of malaria

CharacteristicsNumber
Mean age, yr, n=2347 (range, 24–66)
Sex, n=23
 Men12 (52%)
 Women11 (48%)
Race, n=23
 Black22 (96%)
 White1 (4%)
HIV status, n=23
 Positive10 (43%)
Mean HIV viral load, copies/ml, n=9/10458,000 (range, undetectable to 2.106)
Mean CD4 count, /mm3, n=9/10345 (range, 17–910)
Plasmodium species, n=23
 Plasmodium falciparum22 (96%)
 Plasmodium malariae1 (4%)
Mean parasitemia, %, n=16/237 (range, 0.3–29)
Admission unit, n=23
 ICU11 (48%)
Malaria severity criteria, n=23
 None1 (4.5%)
 %P1 (4.5%)
 AKI15 (64%)
 Neurologic criteriaa1 (4.5%)
 AKI and %P2 (9%)
 AKI and ARDS1 (4.5%)
 AKI and neurologic criteriaa1 (4.5%)
 AKI, neurologic criteria, and %Pa1 (4.5%)
Specific treatment of malaria episode, n=22/23
 Quinine4 (18%)
 Artesunate10 (45%)
 Arteminol piperaquine4 (18%)
 Atovaquone proguanil2 (9%)
 Atovaquone proguanil + artesunate1 (5%)
 Atovaquone proguanil + artesunate + quinine1 (5%)
  • ICU, intensive care unit; %P, parasitemia expressed as a percentage; ARDS, acute respiratory distress syndrome.

  • a Neurologic criteria: neurologic involvement including impaired consciousness and/or prostration and/or multiple convulsions.